SEARCH研究:精简HIV治疗干预降低低CD4男性人群死亡率
在乌干达和肯尼亚32个社区开展整群随机研究,比较精简ART关怀与指南导向ART对CD4≤350/μL HIV感染者的影响。精简关怀使3年死亡率降低28%,男性死亡率降低更显著(RR=0.61),12个月内ART启动率76% vs 43%。
要点
- 精简HIV关怀模式可降低CD4≤350/μL人群的3年死亡率。
- 精简关怀显著加快ART启动,12个月启动率76% vs 43%。
核心结论
- 在人群HIV检测背景下,精简关怀降低了CD4≤350/μL HIV感染者的群体水平死亡率,尤其在男性中。
- 精简HIV关怀模式可能在全球减少艾滋病死亡的努力中发挥关键作用。
研究设计与样本
- SEARCH研究(NCT01864603)为整群随机试验,在乌干达和肯尼亚农村32个社区开展。
- 社区随机分为指南导向ART组与精简ART关怀组,后者包括快速启动ART、就诊间隔延长、灵活门诊时间和友好环境。
- 分析对象为CD4≤350/μL且两组均符合ART条件的HIV感染者,评估3年ART启动和死亡率。
主要发现
- 男性CD4≤350/μL且未治疗的比例几乎为女性两倍(15% vs 8%)。
临床怎么用
- 对CD4≤350/μL的HIV感染者,可采用快速启动ART、延长就诊间隔、灵活门诊时间等精简关怀措施。
- 男性低CD4且未治疗比例较高,精简关怀可能尤其适用于改善男性治疗启动和生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We tested the hypothesis that patient-centered, streamlined human immunodeficiency virus (HIV) care would achieve lower mortality than the standard treatment model for persons with HIV and CD4 ≤ 350/uL in the setting of population-wide HIV testing. METHODS: In the SEARCH (Sustainable East Africa Research in Community Health) Study (NCT01864603), 32 communities in rural Uganda and Kenya were randomized to country-guided antiretroviral therapy (ART) versus streamlined ART care that included rapid ART start, visit spacing, flexible clinic hours, and welcoming environment. We assessed persons with HIV and CD4 ≤ 350/uL, ART eligible in both arms, and estimated the effect of streamlined care on ART initiation and mortality at 3 years. Comparisons between study arms used a cluster-level analysis with survival estimates from Kaplan-Meier; estimates of ART start among ART-naive persons treated death as a competing risk. RESULTS: Among 13 266 adults with HIV, 2973 (22.4%) had CD4 ≤ 350/uL. Of these, 33% were new diagnoses, and 10% were diagnosed but ART-naive. Men with HIV were almost twice as likely as women with HIV to have CD4 ≤ 350/uL and be untreated (15% vs 8%, respectively). Streamlined care reduced mortality by 28% versus control (risk ratio [RR] = 0.72; 95% confidence interval [CI]: .56, .93; P = .02). Despite eligibility in both arms, persons with CD4 ≤ 350/uL started ART faster under streamlined care versus control (76% vs 43% by 12 months, respectively; P < .001). Mortality was reduced substantially more among men (RR = 0.61; 95% CI: .43, .86; P = .01) than among women (RR = 0.90; 95% CI: .62, 1.32; P = .58). CONCLUSIONS: After population-based HIV testing, streamlined care reduced population-level mortality among persons with HIV and CD4 ≤ 350/uL, particularly among men. Streamlined HIV care models may play a key role in global efforts to reduce AIDS deaths.
引用
- Kamya MR, Petersen ML, Kabami J, et al. SEARCH Human Immunodeficiency Virus (HIV) Streamlined Treatment Intervention Reduces Mortality at a Population Level in Men With Low CD4 Counts. Clin Infect Dis. 2021. PMID: 33783495. doi:10.1093/cid/ciaa1782
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。